Medipal HoldingsMAHLY +5.92%78 Interest Coverage is 2,520.24 as of Mar. 2026, which is 128% above its 10-year median of 1,106.04. GuruFocus rates MAHLY with a GF Score™ of 78/100 and a GF Value™ of $16.92 (Fairly Valued). The stock has 1 warning sign investors should review. Among 89 Medical Distribution companies, Medipal Holdings ranks better than 95.51% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medipal Holdings's
Operating Income
for the
three
months ended in Mar. 2026 was $63 Mil. Medipal Holdings's Interest Expense for the
three
months ended in Mar. 2026 was $-0 Mil.
Medipal Holdings's interest coverage for the quarter that ended in Mar. 2026 was 2,520.24.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Medipal Holdings Corp has no debt.
The historical rank and industry rank for Medipal Holdings's Interest Coverage or its related term are showing as below:
MAHLY'
s Interest Coverage Range Over the Past 10 Years
Min: 130.87 Med: 1106.04 Max: 7944.71
Current: 4091.31
MAHLY's Interest Coverage is ranked better than 95.51% of 89
companies
in the Medical Distribution industry
Industry Median: 6.23
vs MAHLY: 4091.31
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medipal Holdings Interest Coverage Related Terms
Medipal Holdings Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MAHLY vs MCK, CAH, COR: Interest Coverage Comparison
For the Medical Distribution subindustry, Medipal Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Interest Coverage of 2,520.24 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medipal Holdings and its competitors. This is 128% above median its historical median of 1,106.04. Over the past decade, Medipal Holdings' Interest Coverage has ranged from 130.87 to 7,944.71. According to the industry distribution chart, Medipal Holdings ranks #4 out of 89 companies in the Medical Distribution industry, placing it in the top 4.5%.
Is Medipal Holdings' Interest Coverage too high?
Medipal Holdings' current Interest Coverage of 2,520.24 is 128% above median its 10-year median of 1,106.04. Over the past 10 years, this metric has ranged from a low of 130.87 to a high of 7,944.71. The Medical Distribution industry median Interest Coverage is 6.23. Medipal Holdings' value of 2,520.24 is 40353.3% above this industry median. Based on the distribution chart, Medipal Holdings ranks #4 out of 89 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Interest Coverage compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #4 out of 89 companies for Interest Coverage. This places Medipal Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 6.23. Medipal Holdings' value of 2,520.24 is 40353.3% above this benchmark. Historically, Medipal Holdings' own Interest Coverage has ranged from 130.87 to 7,944.71 over the past decade. While the company's 10-year median is 1,106.04 vs. the industry median of 6.23, Medipal Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Interest Coverage of 2,520.24 is 40353.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Interest Coverage is 2,520.24, which is 128% above median its own 10-year median of 1,106.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.92, compared to a current price of $16.28 — trading 3.8% below its estimated fair value. The current Interest Coverage is 2,520.24, which is 128% above median its 10-year median of 1,106.04 and 40353.3% above the Medical Distribution industry median of 6.23. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Interest Coverage is 2,520.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $16.28 is trading 3.8% below its estimated GF Value™ of $16.92.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Interest Coverage: 2,520.24 (128% above median its 10-year median of 1,106.04)
GF Value™: $16.92 vs. price of $16.28 (3.8% below fair value)
Industry Position: 40353.3% above the Medical Distribution median (#4 of 89)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
